GeoVax Labs, Inc. (GOVX): Nasdaq/NYSE listing notice — GeoVax receives Nasdaq delisting notice for bid price under $1; will appeal, plans reverse split

GeoVax Labs, Inc.

On Dec 6, 2023, Nasdaq notified GeoVax that its common stock failed to maintain minimum $1 bid price (Nasdaq Rule 5550(a)(2)).
GeoVax will request a hearing to appeal the delisting; the request stays delisting pending the Panel decision.
The company plans a Special Stockholders Meeting on Jan 16, 2024 to seek approval for a reverse stock split.
If the reverse split is approved, GeoVax believes it can regain compliance with the Bid Price Requirement.

item 3.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

GeoVax Labs, Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: delisting notice
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

December 6, 2023, the Company received a notice (the “Notice”) from The Nasdaq Stock Market, LLC ("Nasdaq") stating that Nasdaq has determined to delist the Company's securities from the Nasdaq Capital Market for failure to maintain a minimum bid price of $1.00 per share in accordance with Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Requirement”). The Company intends to appeal the Nasdaq determination by requesting a hearing (the "Hearing") before a Nasdaq Hearings Panel (the "Panel") to seek continued listing pending its return to compliance with the Bid Price Requirement. The Hearing requ

View on SEC.gov

Browse all listing & compliance notices →

GeoVax Labs, Inc. filing history →

Source: SEC EDGAR

accession 0001437749-23-033995

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.